These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3252975)

  • 41. Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.
    Robays J; Raguenaud ME; Josenando T; Boelaert M
    Trop Med Int Health; 2008 Feb; 13(2):265-71. PubMed ID: 18304274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis.
    Blum J; Nkunku S; Burri C
    Trop Med Int Health; 2001 May; 6(5):390-400. PubMed ID: 11348533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. African trypanosomiasis in two travelers from the United States.
    Sinha A; Grace C; Alston WK; Westenfeld F; Maguire JH
    Clin Infect Dis; 1999 Oct; 29(4):840-4. PubMed ID: 10589900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The monitoring of trypanocidal treatment with a sensitive ELISA method for measuring melarsoprol levels in serum and in cerebrospinal fluids.
    Maes L; Vanderveken M; Hamers R; Doua F; Cattand P
    Ann Soc Belg Med Trop; 1988 Sep; 68(3):219-31. PubMed ID: 3223784
    [No Abstract]   [Full Text] [Related]  

  • 45. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness.
    Buguet A; Bisser S; Josenando T; Chapotot F; Cespuglio R
    Acta Trop; 2005 Jan; 93(1):107-17. PubMed ID: 15589803
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy, relapses and CNS in experimental African trypanosomiasis.
    Poltera AA
    Contrib Microbiol Immunol; 1983; 7():155-64. PubMed ID: 6825437
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of human African trypanosomiasis.
    Dumas M; Bouteille B
    Bull World Health Organ; 2000; 78(12):1474. PubMed ID: 11196500
    [No Abstract]   [Full Text] [Related]  

  • 48. Effects of Mel B arsobal and alpha-difluoromethylornithine on the awakening electroencephalogram of humans with gambiense trypanosomiasis disease: preliminary report.
    Hamon JF; Seri B; Doua F; Camara P; Aba L
    Pharmacol Biochem Behav; 1990 Aug; 36(4):831-5. PubMed ID: 2217510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Melarsoprol].
    Simon F
    Med Trop (Mars); 1999; 59(4):331-2. PubMed ID: 10816741
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children.
    Eperon G; Schmid C; Loutan L; Chappuis F
    Acta Trop; 2007 Jan; 101(1):31-9. PubMed ID: 17207760
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.
    Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C
    Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Sleeping sickness in children at Bobo-Dioulasso Hospital Center: apropos of 3 cases].
    Millogo A; Nacro B; Bonkoungou P; Sanou M; Traoré S; Traoré H; Tall F
    Bull Soc Pathol Exot; 1999 Dec; 92(5):320-2. PubMed ID: 10690468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Human African trypanosomiasis in children. A pediatrics service experience in Libreville, Gabon].
    Koko J; Dufillot D; Gahouma D; Amblard J; Kani F
    Bull Soc Pathol Exot; 1997; 90(1):14-8. PubMed ID: 9264741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The treatment of advanced trypanosomiasis rhodesiense with mel B.
    TAUBE E; NIXON LC
    Cent Afr J Med; 1958 Apr; 4(4):141-7. PubMed ID: 13547140
    [No Abstract]   [Full Text] [Related]  

  • 56. [Human African trypanosomiasis in Ivory Coast: biological characteristics after treatment. 812 cases treated in the Daloa focus (Ivory Coast)].
    Miezan TW; Dje NN; Doua F; Boa F
    Bull Soc Pathol Exot; 2002 Dec; 95(5):362-5. PubMed ID: 12696377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arsobal in the treatment of Rhodesian sleeping-sickness.
    SILVA MA; CASEIRO A; CARMO RP; DE BASTO AX
    An Inst Med Trop (Lisb); 1954 Jun; 11(2):261-85. PubMed ID: 13314057
    [No Abstract]   [Full Text] [Related]  

  • 58. The treatment of advanced cases of Rhodesian sleeping sickness by Mel. B. and arsobal.
    APTED FI
    Trans R Soc Trop Med Hyg; 1953 Sep; 47(5):387-98. PubMed ID: 13102579
    [No Abstract]   [Full Text] [Related]  

  • 59. [Role of corticoids in treatment of human African trypanosomiasis].
    Bertrand E; Rive J; Baudin L; Barabe P; Aye H
    Bull Soc Pathol Exot Filiales; 1968; 61(4):617-25. PubMed ID: 5756658
    [No Abstract]   [Full Text] [Related]  

  • 60. [Use of arsobal in the treatment of sleeping sickness].
    NEUJEAN G
    An Inst Med Trop (Lisb); 1952 Sep; 9(3):757-61. PubMed ID: 13092457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.